Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Bigfoot Biomedical, founded in 2014 and based in Milpitas, California, is a company dedicated to improving the lives of people with insulin-requiring diabetes through innovative technology. The company's approach involves delivering Internet-of-Things (IoT) medical devices and cloud-connected systems as part of a monthly subscription service. Bigfoot Biomedical has made significant strides in the healthcare technology sector, raising a total of $162.63 million in funding since its inception.
In September 2023, Bigfoot Biomedical was acquired by Abbott, a major player in the healthcare industry. This acquisition marks a significant milestone for the company and could potentially impact any future plans for going public. The terms of the acquisition were not disclosed, making it difficult to speculate on the company's current valuation or future prospects.
Given the recent acquisition by Abbott, it's unlikely that Bigfoot Biomedical will pursue an initial public offering (IPO) in the near future. Typically, when a company is acquired, it becomes part of the larger organization and ceases to operate as an independent entity in the public markets. However, it's important to note that we don't have any concrete information about Bigfoot Biomedical's IPO prospects at this time.
For investors interested in gaining exposure to Bigfoot Biomedical's technology and market potential, they may want to consider looking into Abbott's stock, as Bigfoot Biomedical is now part of Abbott's portfolio. As always, potential investors should conduct thorough research and consider consulting with financial advisors before making any investment decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Bigfoot Biomedical's IPO prospects remain uncertain, investors eager to explore opportunities in the innovative medical device space don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides the opportunity to invest in potential leaders in the healthcare and biotech sectors, including companies like Bigfoot Biomedical, with lower minimum investments than traditional private equity opportunities. This allows you to potentially benefit from their growth and innovation before they hit the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
